Brokerage sees regulatory revival, market-share recovery and margin expansion as key drivers; stock trades higher in Friday’s ...

Despite the massive recovery – the stock has delivered solid returns of 55 per cent over the last six months and 43 per cent ...

Goldman Sachs upgraded Paytm to ‘Buy’ and doubled its price target to Rs 1,570, citing improving regulatory conditions, better earnings visibility, and a recovery in market share. Other brokerages ...

Paytm shares rose 3.4% to ₹1,325 after Goldman Sachs upgraded its rating to ‘Buy’ and raised the target price to ₹1,570. The ...

Canara Robeccos debut faded fast, with the stock down 9% after weak Q1 numbers. Its a concern for new investors, and its not ...

The foreign brokerage believes the regulatory environment, which had previously been a key drag on the stock price in past, ...

Despite valuation worries and sector setbacks, 2025’s startup IPOs delivered decisive wins—multi-bagger VC returns, founder-billionaires, strong subscriptions, and renewed public-market faith—even as ...

(Reuters) -Indian fintech firm Pine Labs has cut the size of its initial public offering, trimming by 44% the portion offered by existing investors and by 20% the new shares issued to raise funds, an ...